Leadership Development Programs
Strong leadership builds stronger...
Trazodone 50 mg in the Treatment of Major Depressive Disorder and Anxiety
Trazodone functions by altering the levels of neurotransmitters in the brain, particularly serotonin. Serotonin levels in the synaptic cleft are raised as a result of modulation and inhibition of its reuptake. As a result, stability of mood and a decrease in depressive symptoms are promoted. Trazodone's ability to agonistically bind particular serotonin receptors affects its anxiolytic (anxiety-reducing) effects as well.
Please login to comment on this Post